Cusack Thomas
SEC CIK 2094824 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS, INC. /DE/ | Dir | 54.0K | — | — | 2 | 2025-11-08 | 2026-01-30 |
Most active insiders at HRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cusack Thomas | Dir | — | — |
| 2 | Hensley Mark Earl | COO | — | — |
| 3 | Morgan Adam | Dir | — | — |
| 4 | Rosen David Efraim | 10% | — | — |
| 5 | Dissanaike Sharmila | Dir | — | — |
| 6 | Kaseta Michael | Dir | — | — |
| 7 | Christian Waage | Dir | — | — |
| 8 | Duarte Ira | EVP, CFO | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Collard Craig A | CEO, Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-03 | 2026-01-30 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Cusack Thomas | Dir | A - Grant | $0.00 | +54.0K | 54.0K | New | $0 | |
| D | 2025-11-12 | 2025-11-08 | HRTX | HERON THERAPEUTICS, INC. /DE/ | Cusack Thomas | Dir | A - Grant | — | +37.9K | 37.9K | New | — |
Purchase Sale Sale after option exercise All abbreviations